What we're about
Advancing prediction, prevention, and precision therapy for patients with rheumatic diseasesWho we are
Over 200 researchers spanning the basic, clinical, and analytical sciencesHow we help
World-class core facilities and investigator support to drive groundbreaking research and launch distinctive careersWhy we care
Patients with rheumatic diseases need better tests and personalized treatments so they can live healthier, longer lives
Recent Publications
- Neutrophils isolated from systemic lupus erythematosus patients exhibit a distinct functional phenotype March 25, 2024
- Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial February 1, 2024
- Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis January 23, 2024
- Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial December 21, 2023
- Association between systemic lupus erythematosus and myasthenia gravis: A population-based National Study November 10, 2023
- Massively Parallel Reporter Assay Confirms Regulatory Potential of hQTLs and Reveals Important Variants in Lupus and Other Autoimmune Diseases August 30, 2023
- Ancestry-based differences in the immune phenotype are associated with lupus activity August 22, 2023